Search Results 171-180 of 17331 for Proto-oncogene
About this study. The primary objective of this study is to determine the confirmed investigator-assessed objective response rate of XMT-1536 (upifitamab ...
Cell Free DNA (Cfdna) Blood Assays for the Detection of EGFR and Other Clinically Relevant Gene Mutations in Patients with Non-Small Cell Lung Cancer.
Investigators in the Mayo Clinic Ovarian Cancer SPORE are assessing DNA topoisomerase 1 (TOP1) inhibitors to treat ovarian cancer.
About this study. The purpose of this study aims to establish a total of 30 new primary prostate cancer cell lines using a portion of biopsy tissue from ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer ...
Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.
About this study. The purposes of this study are to collect prostate surgical samples from metastatic patients to establish xenograft tumor lines for future ...
Recent reports have identified a specific oncogenic mutation L265P of the MYD88 gene in approximately 30% of the patients with the activated B-cell (ABC) type ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.